Forde, Patrick M.
Scherpereel, Arnaud
Tsao, Anne S.
Article History
First Online: 14 February 2019
Compliance with Ethical Standards
:
: Patrick M. Forde has received a research funding from AstraZeneca, Bristol-Myers Squibb, Corvus, Kyowa Kirin, and Novartis and has received compensation from AbbVie, Astra Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, EMD Serono, Inivata, Eli Lilly, Merck, and Novartis for the service on advisory boards and/or as a consultant.Arnaud Scherpereel has received a research funding (paid to his institution) from Bristol-Myers Squibb and MSD; has received a compensation from AstraZeneca, Bristol-Myers Squibb, MSD, and Roche for participation on advisory boards and/or lectures provided; and has received a travel support to international meetings on thoracic oncology from Bristol-Myers Squibb, MSD, and Roche.Anne S. Tsao has received a research funding from Bristol-Myers Squibb, Genentech/Roche, Eli Lilly, Millennium, Seattle Genetics, Ariad, Boehringer Ingelheim, Polaris, Epizyme, Merck, AstraZeneca, and Takeda and has received compensation from Bristol-Myers Squibb, Genentech/Roche, Ariad, Boehringer Ingelheim, AstraZeneca, and Takeda for the participation on advisory boards.
: This article does not contain any studies with human or animal subjects performed by any of the authors.